Literature DB >> 20152846

Measuring persistent temporomandibular joint nociception in rats and two mice strains.

Phillip R Kramer1, Carolyn A Kerins, Emet Schneiderman, Larry L Bellinger.   

Abstract

Temporomandibular joint (TMJ) pain has been reported to last for prolonged periods in humans. In rodents a variety of methods have been used to measure TMJ nociception, but for most of these methods the period of measurement has been minutes to a couple of hours. In addition, most measurement protocols required restraint or training of the animal. Previous studies from our laboratory demonstrated that feeding behavior, particularly meal duration, was an indicator of TMJ nociception in unrestrained and untrained male and female Sprague-Dawley rats for up to two days. In this study, we first found that injection of complete Freund's adjuvant (CFA) into the TMJ of rats significantly lengthened meal duration for 19 days and also decreased meal frequency for 42 days. Interestingly, the meal duration varied significantly from day to day within the 19 day period. TMJ interleukin-1 beta (IL-1 beta) and calcitonin gene-related peptide (CGRP) were significantly elevated in the TMJ tissues of CFA-injected animals and the level of these markers was attenuated as the meal duration decreased with time. Control animals injected with saline into the TMJ or CFA into the knee did not show a significant lengthening in meal duration but did show a decrease in meal frequency. In a second study, DBA/1LacJ mice given TMJ CFA injections showed a significantly lengthened meal duration on four of the seven days measured using end-of-the meal definition of 5 or 10 min. No other meal pattern changed significantly. Two days post-CFA injection, the DBA/1LacJ mice showed significantly elevated interleukin-6 (IL-6), but not elevated IL-1 beta. Seven days post-injection, both IL-6 and IL-1 beta were significantly elevated. No change in CGRP was detected. In this study C57Bl/6 mice also received TMJ CFA injections, but they did not show a lengthening in any meal pattern or significant increases in IL-1 beta, IL-6 or CGRP. Our data show, for the first time, that meal duration can be used to measure CFA-induced nociception in the TMJ over the course of several weeks in unrestrained rats and for up to seven days in the DBA/1LacJ mouse strain. In addition, C57Bl/6 mice are resistant to CFA-induced TMJ nociception at the same dose used in the DBA/1LacJ mice. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20152846      PMCID: PMC2854343          DOI: 10.1016/j.physbeh.2010.01.037

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  52 in total

1.  Difficulty of food intake in patients with temporomandibular disorders.

Authors:  Tadasu Haketa; Koji Kino; Masashi Sugisaki; Yoko Amemori; Takayuki Ishikawa; Toshihisa Shibuya; Fumiaki Sato; Nahoko Yoshida
Journal:  Int J Prosthodont       Date:  2006 May-Jun       Impact factor: 1.681

2.  Use of a novel thermal operant behavioral assay for characterization of orofacial pain sensitivity.

Authors:  John K Neubert; Charles G Widmer; Wendi Malphurs; Heather L Rossi; Charles J Vierck; Robert M Caudle
Journal:  Pain       Date:  2005-08       Impact factor: 6.961

3.  Inflammatory cytokines correlated with clinical outcome of temporomandibular joint irrigation in patients with chronic closed lock.

Authors:  Yoshiki Hamada; Toshirou Kondoh; Anders B Holmlund; Matsuo Yamamoto; Akihisa Horie; Tomoyuki Saito; Ko Ito; Kanichi Seto; Hideki Sekiya
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2006-07-18

4.  Inflammatory cell and cytokine patterns in patients with chronic polyarthritis and temporomandibular joint involvement.

Authors:  Ramin Kardel; Ann-Kristin Ulfgren; Finn Reinholt; Yoshiki Hamada; Anders Holmlund
Journal:  Acta Odontol Scand       Date:  2006-08       Impact factor: 2.331

5.  Insufficient endogenous control of tumor necrosis factor-alpha contributes to temporomandibular joint pain and tissue destruction in rheumatoid arthritis.

Authors:  Per Alstergren; Sigvard Kopp
Journal:  J Rheumatol       Date:  2006-09       Impact factor: 4.666

6.  Specificity of meal pattern analysis as an animal model of determining temporomandibular joint inflammation/pain.

Authors:  C A Kerins; D S Carlson; R J Hinton; B Hutchins; D M Grogan; K Marr; P R Kramer; R D Spears; L L Bellinger
Journal:  Int J Oral Maxillofac Surg       Date:  2005-06       Impact factor: 2.789

7.  Capsaicin sensitive neurons role in the inflamed TMJ acute nociceptive response of female and male rats.

Authors:  Larry L Bellinger; Robert Spears; Christopher M King; Fred Dahm; Bob Hutchins; Carolyn A Kerins; Phillip R Kramer
Journal:  Physiol Behav       Date:  2007-01-18

8.  An operant conditioning model to assess changes in feeding behavior associated with temporomandibular joint inflammation in the rat.

Authors:  Paul D Thut; Tracey O Hermanstyne; Natasha M Flake; Michael S Gold
Journal:  J Orofac Pain       Date:  2007

9.  Manipulation of the induction of adjuvant arthritis in Sprague-Dawley rats.

Authors:  X Cai; Y F Wong; H Zhou; Z Q Liu; Y Xie; Z H Jiang; Z X Bian; H X Xu; L Liu
Journal:  Inflamm Res       Date:  2006-09       Impact factor: 4.575

10.  Species differences in the effect of pregnancy on lymphocyte cytokine production between human and rat.

Authors:  Marijke M Faas; Annechien Bouman; Angelique L Veenstra van Nieuwenhoven; Gerda van der Schaaf; Henk Moes; Maas Jan Heineman; Paul de Vos
Journal:  J Leukoc Biol       Date:  2005-07-20       Impact factor: 4.962

View more
  17 in total

1.  Infusion of Gabrα6 siRNA into the trigeminal ganglia increased the myogenic orofacial nociceptive response of ovariectomized rats treated with 17β-estradiol.

Authors:  P R Kramer; L L Bellinger
Journal:  Neuroscience       Date:  2014-08-12       Impact factor: 3.590

2.  Meal duration as a measure of orofacial nociceptive responses in rodents.

Authors:  Phillip R Kramer; Larry L Bellinger
Journal:  J Vis Exp       Date:  2014-01-10       Impact factor: 1.355

3.  Capping a pulpotomy with calcium aluminosilicate cement: comparison to mineral trioxide aggregates.

Authors:  Phillip R Kramer; Karl F Woodmansey; Robert White; Carolyn M Primus; Lynne A Opperman
Journal:  J Endod       Date:  2014-04-08       Impact factor: 4.171

4.  Knockdown of Fcγ receptor III in an arthritic temporomandibular joint reduces the nociceptive response in rats.

Authors:  Phillip R Kramer; Jyoti Puri; Larry L Bellinger
Journal:  Arthritis Rheum       Date:  2010-10

5.  Reduced GABA(A) receptor α6 expression in the trigeminal ganglion alters inflammatory TMJ hypersensitivity.

Authors:  J Puri; P Vinothini; J Reuben; L L Bellinger; L Ailing; Y B Peng; P R Kramer
Journal:  Neuroscience       Date:  2012-04-19       Impact factor: 3.590

6.  Intra-articular controlled release of anti-inflammatory siRNA with biodegradable polymer microparticles ameliorates temporomandibular joint inflammation.

Authors:  Paschalia M Mountziaris; Stephanie N Tzouanas; David C Sing; Phillip R Kramer; F Kurtis Kasper; Antonios G Mikos
Journal:  Acta Biomater       Date:  2012-06-28       Impact factor: 8.947

7.  Reduced GABAA receptor α6 expression in the trigeminal ganglion enhanced myofascial nociceptive response.

Authors:  P R Kramer; L L Bellinger
Journal:  Neuroscience       Date:  2013-04-18       Impact factor: 3.590

Review 8.  Review of preclinical studies on treatment of mucositis and associated pain.

Authors:  C T Viet; P M Corby; A Akinwande; B L Schmidt
Journal:  J Dent Res       Date:  2014-06-18       Impact factor: 6.116

9.  Chronic inflammatory pain prevents tolerance to the antinociceptive effect of morphine microinjected into the ventrolateral periaqueductal gray of the rat.

Authors:  Melissa L Mehalick; Susan L Ingram; Sue A Aicher; Michael M Morgan
Journal:  J Pain       Date:  2013-10-22       Impact factor: 5.820

10.  A non-invasive model for measuring nociception after tooth pulp exposure.

Authors:  P R Kramer; J He; J Puri; L L Bellinger
Journal:  J Dent Res       Date:  2012-07-12       Impact factor: 6.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.